Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 305960 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 349708 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1104 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1130 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1264 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1295 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1721 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 1807 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 2807 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 20542 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 27186 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1005 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1036 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1078 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1111 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1119 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1207 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1230 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1251 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1260 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1404 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1424 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1427 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1469 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1562 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1662 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1686 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1764 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1867 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 1903 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2055 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2055 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2189 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2259 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2385 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2386 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2803 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 2951 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 3018 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 3463 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 42651 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | 78681 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |